SUCCESSFUL TREATMENT OF ANKYLOSING SPONDYLITIS
WITH RIFAXIMIN

Rifaximin for AS [researchgate.net]

We estimate that 2 out of 3 patients with AS
will significantly improve the symptoms
they have suffered for years or decades
in just 2 to 6 days after starting the proposed treatment.

We make our experience public and share it with the aim of having an effective treatment that helps many patients in the short term.

The described protocol is also applicable to patients with: Rheumatoid Arthritis, Psoriatic Arthritis, Sjögren's Syndrome, Lupus, Sclerosis, Myositis, Fibromyalgia, Chronic pain, Stiff Person Syndrome, Antiphospholipid Syndrome and other diseases considered rheumatic and autoimmune that are associated with the presence of intestinal dysbiosis.